Kangmei Pharmaceutical Co Ltd Financial Flexibility Index
Kangmei Pharmaceutical Co Ltd financial flexibility index. Kangmei Pharmaceutical Co Ltd (600518) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥268.53 Million (operating CF CN¥219.96 Million minus capex CN¥48.57 Million) represents 0% of total liabilities (CN¥6.46 Billion). See free cash flow generation of Kangmei Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Kangmei Pharmaceutical Co Ltd (1999–2024)
Financial flexibility index of Kangmei Pharmaceutical Co Ltd from 1999 to 2024. Historical Financial Flexibility Index trend for Kangmei Pharmaceutical Co Ltd across 26 annual periods. Check 600518 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Kangmei Pharmaceutical Co Ltd Financial Flexibility Index by Year (1999–2024)
Kangmei Pharmaceutical Co Ltd financial flexibility index by year from 1999 to 2024. Year-by-year free cash flow to debt coverage for Kangmei Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Kangmei Pharmaceutical Co Ltd cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.06x | CN¥-365.92 Million | CN¥-427.63 Million | CN¥6.59 Billion | ▼ -83.6% |
| 2023 | -0.03x | CN¥-217.78 Million | CN¥-317.52 Million | CN¥7.20 Billion | ▲ +64.7% |
| 2022 | -0.09x | CN¥-701.84 Million | CN¥-749.96 Million | CN¥8.18 Billion | ▼ -235.3% |
| 2021 | 0.06x | CN¥385.83 Million | CN¥214.21 Million | CN¥6.09 Billion | ▲ +108.0% |
| 2020 | 0.03x | CN¥1.33 Billion | CN¥1.03 Billion | CN¥43.74 Billion | ▼ -60.1% |
| 2019 | 0.08x | CN¥3.36 Billion | CN¥2.88 Billion | CN¥43.94 Billion | ▼ -26.7% |
| 2018 | 0.10x | CN¥4.90 Billion | CN¥305.62 Million | CN¥47.03 Billion | ▲ +242.3% |
| 2017 | -0.07x | CN¥-2.69 Billion | CN¥-4.84 Billion | CN¥36.78 Billion | ▼ -158.7% |
| 2016 | 0.12x | CN¥3.17 Billion | CN¥1.60 Billion | CN¥25.44 Billion | ▲ +27.5% |
| 2015 | 0.10x | CN¥1.88 Billion | CN¥508.86 Million | CN¥19.27 Billion | ▼ -39.9% |
| 2014 | 0.16x | CN¥1.81 Billion | CN¥1.13 Billion | CN¥11.16 Billion | ▼ -30.1% |
| 2013 | 0.23x | CN¥2.38 Billion | CN¥1.67 Billion | CN¥10.22 Billion | ▼ -28.9% |
| 2012 | 0.33x | CN¥2.41 Billion | CN¥1.01 Billion | CN¥7.38 Billion | ▼ -32.3% |
| 2011 | 0.48x | CN¥2.90 Billion | CN¥574.96 Million | CN¥5.99 Billion | ▲ +10.4% |
| 2010 | 0.44x | CN¥1.44 Billion | CN¥669.19 Million | CN¥3.28 Billion | ▲ +0.9% |
| 2009 | 0.43x | CN¥843.72 Million | CN¥119.47 Million | CN¥1.95 Billion | ▼ -19.5% |
| 2008 | 0.54x | CN¥696.16 Million | CN¥3.02 Million | CN¥1.29 Billion | ▼ -3.1% |
| 2007 | 0.56x | CN¥490.78 Million | CN¥162.55 Million | CN¥882.71 Million | ▼ -11.6% |
| 2006 | 0.63x | CN¥481.77 Million | CN¥68.32 Million | CN¥766.30 Million | ▼ -12.5% |
| 2005 | 0.72x | CN¥155.53 Million | CN¥133.13 Million | CN¥216.45 Million | ▲ +7.5% |
| 2004 | 0.67x | CN¥228.72 Million | CN¥78.52 Million | CN¥342.09 Million | ▲ +38.4% |
| 2003 | 0.48x | CN¥126.65 Million | CN¥78.02 Million | CN¥262.25 Million | ▼ -55.0% |
| 2002 | 1.07x | CN¥255.88 Million | CN¥53.47 Million | CN¥238.35 Million | ▲ +23.8% |
| 2001 | 0.87x | CN¥132.23 Million | CN¥15.69 Million | CN¥152.51 Million | ▲ +852.1% |
| 2000 | 0.09x | CN¥11.59 Million | CN¥9.96 Million | CN¥127.27 Million | ▼ -75.6% |
| 1999 | 0.37x | CN¥43.21 Million | CN¥30.25 Million | CN¥115.77 Million | — |